FdaApprovalPulse: Generic drug approval (ANDA)
196 fdaApprovalPulse: Generic drug approval (ANDA) are listed from openFDA device PMA and Drugs@FDA endpoints (U.S. Food and Drug Administration), dated 2026-05-01 to 2026-10-28; the most frequent is MSN with 13. Data last updated 2026-11-04; each record links to its official source and a full report.
Data as of · Compiled by Zalwin from openFDA device PMA and Drugs@FDA endpoints (U.S. Food and Drug Administration)
Includes: Sponsor, Product, Approval, Decided, official source URL and score · Card, Apple Pay, Google Pay or Link via Stripe
196 records from openFDA device PMA and Drugs@FDA endpoints (U.S. Food and Drug Administration), dated 2026-05-01 to 2026-10-28. Most frequent: MSN (13). Each record links to a full report and the official source.
Last updated 2026-11-04. Source: openFDA device PMA and Drugs@FDA endpoints (U.S. Food and Drug Administration).
Get new FdaApprovalPulse records by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
- MSN (13)
- AUROBINDO PHARMA LTD (13)
- ALEMBIC (9)
- MICRO LABS (9)
- LUPIN (8)
How do I get new fdaApprovalPulse: Generic drug approval (ANDA) by email?
Search, filter and export these records, or get alerts when new ones appear.
What are the top fdaApprovalPulse: Generic drug approval (ANDA) right now?
| Record | Product | Approval | Decided |
|---|---|---|---|
| ALEMBIC | VENETOCLAX | Generic drug approval (ANDA) | 2026-10-28 |
| NEURORX | KETAMINE HYDROCHLORIDE | Generic drug approval (ANDA) | 2026-10-28 |
| ALEMBIC | VALGANCICLOVIR HYDROCHLORIDE | Generic drug approval (ANDA) | 2026-10-26 |
| GLAND | EPINEPHRINE | Generic drug approval (ANDA) | 2026-10-26 |
| BIONPHARMA | TRIMETHOPRIM | Generic drug approval (ANDA) | 2026-10-23 |
| MSN | AFATINIB DIMALEATE | Generic drug approval (ANDA) | 2026-10-21 |
| CADILA PHARMS LTD | AMLODIPINE BESYLATE AND VALSARTAN | Generic drug approval (ANDA) | 2026-10-21 |
| TEVA PHARMS INC | DEFLAZACORT | Generic drug approval (ANDA) | 2026-10-19 |
| KINDOS | ERIBULIN MESYLATE | Generic drug approval (ANDA) | 2026-10-19 |
| AJANTA PHARMA LTD | TOFACITINIB CITRATE | Generic drug approval (ANDA) | 2026-10-19 |
| NOVAST LABS | PROGESTERONE | Generic drug approval (ANDA) | 2026-10-16 |
| CIPLA | CABOZANTINIB S-MALATE | Generic drug approval (ANDA) | 2026-10-16 |
| AUROBINDO PHARMA LTD | UPADACITINIB | Generic drug approval (ANDA) | 2026-10-16 |
| ALEMBIC | CIPROFLOXACIN AND DEXAMETHASONE | Generic drug approval (ANDA) | 2026-10-15 |
| AMNEAL | SODIUM PHOSPHATES | Generic drug approval (ANDA) | 2026-10-15 |
| GLAND | 🔒 Unlock all 196 records → | ||
| HIKMA | 🔒 Unlock all 196 records → | ||
| SHANDONG | 🔒 Unlock all 196 records → | ||
Browse 35 more matching record reports
- GLAND
- HIKMA
- SHANDONG
- AUROBINDO PHARMA LTD
- AUROBINDO PHARMA LTD
- LUPIN
- TARO
- GLAND
- NEPHRON
- UPSHER SMITH LABS
- STERISCIENCE
- AUROBINDO PHARMA LTD
- MEITHEAL
- NEPHRON
- ACTAVIS LABS FL
- SHANDONG
- IPCA LABS LTD
- PHARMAZONE
- LANTHEUS MEDICAL
- AMNEAL
- HIKMA
- BAXTER HLTHCARE CORP
- AUROBINDO PHARMA LTD
- CIPLA
- APOTEX
- AUROLIFE PHARMA LLC
- AJANTA PHARMA LTD
- MSN
- BAXTER HLTHCARE CORP
- AUROBINDO PHARMA LTD
- HETERO LABS LTD V
- MICRO LABS
- LUPIN
- MSN
- BPI LABS
More records in this hub: page 2
Browse all FdaApprovalPulse record reports
Which related categories and locations should I check?
Browse by approval type
Drug labeling or REMS supplement (1180) PMA supplement (device change) (367) Drug efficacy supplement (new indication or use) (77) Drug manufacturing (CMC) supplement (55) New drug application (NDA) (41) PMA original approval (new class III device) (24) Biologic license (BLA) (17) Other drug supplement (12)
Browse by sponsor state (devices)
California (110) Minnesota (61) Massachusetts (37) Oregon (20) Arizona (18) Texas (18) Illinois (9) Maryland (9) Tennessee (8) Pennsylvania (7) Florida (6) Washington (6) Missouri (5) Wisconsin (5) Colorado (4) Connecticut (4) Georgia (4) Indiana (4) New Jersey (4) New York (4) North Carolina (3) Ohio (3)
Frequently asked questions
How many fdaApprovalPulse: Generic drug approval (ANDA) are listed?
196 records from openFDA device PMA and Drugs@FDA endpoints (U.S. Food and Drug Administration), last refreshed automatically. The most recent is dated 2026-10-28.
Can I get alerts for Generic drug approval (ANDA)?
Yes. FdaApprovalPulse can email you new records matching this filter; plans are listed on the FdaApprovalPulse page.
Source: openFDA device PMA and Drugs@FDA endpoints (U.S. Food and Drug Administration). Informational only. RSS feed of new records